Case report: Single infusion of combined anti-CD20 and anti-CD38 monoclonal antibodies in pediatric refractory lupus nephritis

Lupus nephritis (LN), present in 30%–50% of systemic lupus erythematosus (SLE) patients, often necessitates standard immunosuppressive therapy (glucocorticoids, MMF, CYC) as suggested by the European League Against Rheumatism/European Renal Association–European Dialysis and Transplant Association (E...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Decimo Silvio Chiarenza, Raul Mancini, Carolina Bigatti, Gianluca Caridi, Alessandro Consolaro, Valentina Natoli, Gabriele Mortari, Xhuliana Kajana, Francesca Lugani, Marco Gattorno, Gian Marco Ghiggeri, Edoardo La Porta, Gabriele Gaggero, Enrico E. Verrina, Andrea Angeletti
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2025-01-01
Serija:	Frontiers in Immunology
Teme:	systemic lupus erythematous lupus nephritis rituximab daratumumab monoclonal antibodies pediatric
Online dostop:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1525892/full
Oznake:	Označite Brez oznak, prvi označite!